Sou FM, Hsu CN, Chiu YC, Wu CK, Lu LS, Kuo CM, Chiu SM, Chuah SK, Yang YH, Liang CM*. ?The association between trajectory of serum cholesterol, statin dosage, and the risk of recurrent biliary stone diseases. J Formos Med Assoc. 2024 Apr 7:S0929-6646(24)00203-1. (SCI) 【待登錄】
Sou FM, Hu TH, Hung CH, Lai HC, Wang JH, Lu SN, Peng CY*, Chen CH*. Incidence and predictors of hepatocellular carcinoma beyond year 5 of entecavir therapy in chronic hepatitis B patients. Hepatol Int. 2020 Jul;14(4):513-520. (SCI) 慢性B型肝炎病患接受貝樂克治療5年後發生肝癌的機率和預測因子
Sou FM, Wu CK, Chang KC, Lu SN, Wang JH, Hung CH, Chen CH, Kee KM, Yen YH, Lin MT, Tsai MC, Hu TH*.Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders. J Formos Med Assoc. 2019 Jan;118(1 Pt 3):504-513. (SCI) C型肝炎經干擾素治療後發生肝癌的特徵與預後之比較